SNRI ' Shows Promise ' for Comorbid ADHD, PTSD SNRI ' Shows Promise ' for Comorbid ADHD, PTSD
The SNRI atomoxetine may help improve outcomes for patients with both attention-deficit/hyperactivity disorder and posttraumatic stress disorder, new research suggests.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Psychiatry News Source Type: news
More News: ADHD | Hyperactivity | Internal Medicine | Post Traumatic Stress Disorder | Psychiatry | Strattera